Get the Stockscreener App
7.49
0.13%
-0.010
After Hours:
7.49
Kamada Ltd stock is traded at $7.49, with a volume of 30,556.
It is down -0.13% in the last 24 hours and up +4.46% over the past month.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
See More
Previous Close:
$7.50
Open:
$7.5
24h Volume:
30,556
Relative Volume:
0.63
Market Cap:
$432.13M
Revenue:
$181.68M
Net Income/Loss:
$20.37M
P/E Ratio:
21.43
EPS:
0.3495
Net Cash Flow:
$17.31M
1W Performance:
+1.77%
1M Performance:
+4.46%
6M Performance:
+0.81%
1Y Performance:
-4.95%
1-Day Range:
$7.46
$7.525
1-Week Range:
$7.32
$7.71
52-Week Range:
$6.50
$9.35
Kamada Ltd Stock (KMDA) Company Profile
Compare KMDA vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
7.49 | 423.48M | 181.68M | 20.37M | 17.31M | 0.3495 |
TAK
Takeda Pharmaceutical Co Adr
|
16.89 | 50.65B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.72 | 41.09B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.29 | 39.45B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
75.42 | 30.13B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
547.25 | 23.00B | 3.17B | 1.29B | 1.01B | 27.09 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Initiated | The Benchmark Company | Buy |
| Jul-03-24 | Initiated | Stifel | Buy |
| Feb-02-18 | Initiated | Chardan Capital Markets | Buy |
Kamada Ltd Stock (KMDA) Latest News
Trading Systems Reacting to (KMDA) Volatility - Stock Traders Daily
KMDAKamada Ltd Latest SEC Filings - Finviz
Kamada Ltd updates drug portfolio as Nasdaq-listed biopharma pursues growth - AD HOC NEWS
Daichi Kamada Contract Boost Gives Crystal Palace Sage Win - Read Crystal Palace
Kamada Ltd Actuals & Estimates (NASDAQ:KMDA) - TradingView
Kamada eyed by Milan and Fiorentina as Crystal Palace midfielder linked with Serie A return - Football Italia
KMDA Forecast — Price Target — Prediction for 2027 - TradingView
KMDA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Kamada Ltd (KMDA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Daichi Kamada World Cup form gives Crystal Palace fresh momentum - Read Crystal Palace
Japan coach Moriyasu praises Kamada after standout performance in new role - CNA
FIFA World Cup 2026: Japan rout Tunisia in World Cup's 1,000th match - Rediff
Japan takes step toward knockout stage with 4-0 rout of Tunisia - The Japan Times
Tunisia Vs Japan, FIFA World Cup 2026 In Pics: See Best Photos From Estadio Monterrey - Outlook India
Kamada strikes early to take Japan 1-0 lead against Tunisia - Views Bangladesh
Japan turn to Kamada, Ito with Kubo sidelined for Tunisia clash - CNA
How Kamada Ltd. (KMDA) Affects Rotational Strategy Timing - Stock Traders Daily
Kamada Stockweekly review against biotech peers - AD HOC NEWS
Kamada schedules annual shareholder meeting for August in Rehovot By Investing.com - Investing.com Canada
Kamada schedules annual shareholder meeting for August in Rehovot - Investing.com
Kamada (NASDAQ: KMDA) plans 2026 AGM on directors, option grants and ISO pool - Stock Titan
Kamada Ltd (KMDA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Kamada Ltd (KMDA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Kamada Ltd (KMDA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Kamada Ltd (KMDA) Institutional Confidence - TradingKey
Kamada Ltd (KMDA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Kamada Ltd (KMDA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Kamada Ltd (KMDA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TXG Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
KMDA News | KAMADA LTD (NASDAQ:KMDA) - ChartMill
Goalscorer Kamada credits ex-Palace boss Glasner for his Japan turnaround - The Japan Times
Daichi Kamada steals a point - The Financial Express
Crystal Palace at World Cup: Daichi Kamada reacts to ‘lucky’ equaliser vs Netherlands - Read Crystal Palace
How Kamada became Japan’s unlikely hero in World Cup classic vs Netherlands - The Indian Express
Japan vs Netherlands FIFA World Cup Match Result: Kamada's 88th-minute heroics rescue Japan in dramatic d - The Times of India
Daichi Kamada’s Late Header Gives Japan a 2-2 Draw with the Netherlands in World Cup Opener for Both - Kiripost
World Cup 2026: Kamada’s late header snatches draw for Japan against Netherlands - Business News Nigeria
Netherlands vs Japan highlights: Daichi Kamada’s late equalizer rescues Samurai Blue in FIFA World Cup th - The Times of India
Japan vs Netherlands: Kamada's Late Goal Secures 2-2 Draw - The News Mill
Kamada’s Late Header Earns Japan Thrilling 2-2 Draw Against Netherlands - NewsGhana
FIFA World Cup 2026: Late Kamada goal gives Japan point against NetherlandsNED vs JAP player ratings - Sportstar
Kamada Ltd. (KMDA) Holds Steady at $7.44 as Consolidation ContinuesSmart Beta Flow - newsline.com
KMDA Q1 2026 Earnings: EPS Misses Estimates Amid Operational ChallengesRevenue Miss Report - newsline.com
(KMDA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
KMDA Q1 2026 Earnings: EPS Misses Estimates Amid Revenue Disclosure GapRevenue Surprise History - newsline.com
Kamada (KMDA) Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesGuidance Accuracy Score - newsline.com
MRVI Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Why Is Kamada Ltd. (KMDA) Stock Down Today? - Meyka
KMDA Q1 2026 Earnings: EPS Misses Estimates as Stock Slips -2.85%Forward Guidance Trends - newsline.com
Kamada: Undervalued, Yet Execution Risks Keep It A Hold (NASDAQ:KMDA) - Seeking Alpha
Kamada gets FDA approval for Rapid Fluorescent Focus Inhibition Test laboratory - TipRanks
Kamada Ltd Stock (KMDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.03%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):